Publication: Effect of Prognostic Guided Management of Patients With Acute Pulmonary Embolism According to the European Society of Cardiology Risk Stratification Model.
Loading...
Identifiers
Date
2022-04-12
Authors
Jiménez, David
Rodríguez, Carmen
Pintado, Beatriz
Pérez, Andrea
Jara-Palomares, Luis
López-Reyes, Raquel
Ruiz-Artacho, Pedro
García-Ortega, Alberto
Bikdeli, Behnood
Lobo, José Luis
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
A recent trial showed that management driven by prognostic assessment was effective in reducing the length of stay (LOS) for acute stable pulmonary embolism (PE). The efficacy and safety of this strategy in each subgroup of risk stratification remains unknown. We conducted a post-hoc analysis of the randomized IPEP study to evaluate the effect of a management strategy guided by early use of a prognostic pathway in the low- and intermediate-high risk subgroups defined by the European Society of Cardiology (ESC) model. These subgroups were retrospectively identified in the control arm. The primary outcome was LOS. The secondary outcomes were 30-day clinical outcomes. Of 249 patients assigned to the intervention group, 60 (24%) were classified as low-, and 30 (12%) as intermediate-high risk. Among 249 patients assigned to the control group, 66 (27%) were low-, and 13 (5%) intermediate-high risk. In the low-risk group, the mean LOS was 2.1 (±0.9) days in the intervention group and 5.3 (±2.9) days in the control group (P The use of a prognostic assessment and management pathway was effective in reducing the LOS for acute PE without comprising safety across subgroups of risk stratification. [ClinicalTrials.gov], Identifier [NCT02733198].
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
LOS, complications, mortality, prognosis, pulmonary embolism